Ruxrungtham K - Search Results

1

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR. Crane M, et al. Among authors: ruxrungtham k. J Infect Dis. 2009 Apr 1;199(7):974-81. doi: 10.1086/597276. J Infect Dis. 2009. PMID: 19231993 Clinical Trial.

2

Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.

Thisyakorn U, Pancharoen C, Ruxrungtham K, Ubolyam S, Khawplod P, Tantawichien T, Phanuphak P, Wilde H. Thisyakorn U, et al. Among authors: ruxrungtham k. Clin Infect Dis. 2000 Jan;30(1):218. doi: 10.1086/313610. Clin Infect Dis. 2000. PMID: 10619765 No abstract available.

3

A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand.

Ruxrungtham K, Suwanagool S, Tavel JA, Chuenyam M, Kroon E, Ubolyam S, Buranapraditkun S, Techasathit W, Li Y, Emery S, Davey RT, Fosdick L, Kunanusont C, Lane HC, Phanuphak P; Vanguard Study Group. Ruxrungtham K, et al. AIDS. 2000 Nov 10;14(16):2509-13. doi: 10.1097/00002030-200011100-00013. AIDS. 2000. PMID: 11101062 Clinical Trial.

4

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients.

Ungsedhapand C, Kroon ED, Suwanagool S, Ruxrungtham K, Yimsuan N, Sonjai A, Ubolyam S, Buranapraditkun S, Tiengrim S, Pakker N, Kunanusont C, Lange JM, Cooper DA, Phanuphak P. Ungsedhapand C, et al. Among authors: ruxrungtham k. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):116-23. doi: 10.1097/00126334-200106010-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11404532 Clinical Trial.

5

Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy.

Ruxrungtham K, Ubolyam S, Hassink EA, Ungsedhapand C, Kroon E, Duncombe C, Weverling GJ, Nookai S, Lange J, Cooper D, Phanuphak P. Ruxrungtham K, et al. Asian Pac J Allergy Immunol. 2002 Jun;20(2):105-11. Asian Pac J Allergy Immunol. 2002. PMID: 12403195 Free article.

6

Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.

Ananworanich J, Phanuphak N, Nuesch R, Apateerapong W, Rojnuckarin P, Ubolyam S, Phanuphak P, Ruxrungtham K. Ananworanich J, et al. Among authors: ruxrungtham k. Clin Infect Dis. 2003 Sep 1;37(5):723-5. doi: 10.1086/376989. Epub 2003 Aug 12. Clin Infect Dis. 2003. PMID: 12942407

7

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.

Law WP, Dore GJ, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA. Law WP, et al. Among authors: ruxrungtham k. AIDS. 2003 Oct 17;17(15):2191-9. doi: 10.1097/00002030-200310170-00007. AIDS. 2003. PMID: 14523276

8

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ. Law WP, et al. Among authors: ruxrungtham k. AIDS. 2004 May 21;18(8):1169-77. doi: 10.1097/00002030-200405210-00010. AIDS. 2004. PMID: 15166532 Clinical Trial.

9

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.

Ungsedhapand C, Srasuebkul P, Cardiello P, Ruxrungtham K, Ratanasuwan W, Kroon ED, Tongtalung M, Juengprasert N, Ubolyam S, Siangphoe U, Emery S, Lange JM, Cooper DA, Phanuphak P; HIV-NAT 002 and HIV-NAT 003 Study Team. Ungsedhapand C, et al. Among authors: ruxrungtham k. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):693-701. doi: 10.1097/00126334-200406010-00006. J Acquir Immune Defic Syndr. 2004. PMID: 15167288 Clinical Trial.

10

Undetectable plasma HIV-1 RNA with strong gag-pol specific interferon-gamma ELISPOT response in an HIV-1 clade A/E-infected child untreated with antiretroviral therapy.

Ananworanich J, Pancharoen C, Sirivichayakul S, Buranapraditkun S, Apateerapong W, Ubolyam S, Ruxrungtham K. Ananworanich J, et al. Among authors: ruxrungtham k. Asian Pac J Allergy Immunol. 2004 Jun-Sep;22(2-3):165-9. Asian Pac J Allergy Immunol. 2004. PMID: 15565954 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters